Estrogens and atherosclerosis - PubMed (original) (raw)
Review
Estrogens and atherosclerosis
L Nathan et al. Annu Rev Pharmacol Toxicol. 1997.
Abstract
Estrogens prevent heart disease in women and have also been shown to retard atherogenesis in animal models. Estrogens may act at several steps in the atherogenic process to prevent cardiovascular disease. Some of the benefits of estrogens can be ascribed to their ability to favorably alter the lipoprotein profile, i.e. increase high-density lipoprotein and decrease low-density lipoprotein, and also to their ability to prevent oxidative modification of low-density lipoprotein. Other beneficial effects of estrogens include direct actions on the vascular endothelium and vascular smooth muscle, leading to a decrease in the expression of adhesion molecules involved in monocyte adhesion to endothelial cells, and to a decrease in certain chemokines involved in monocyte migration into the subendothelial space. Estrogens may also affect the later stages of atherogenesis. Finally, estrogens may modify the behavior of atherosclerotic vessels by altering their reactivity and thereby promoting vasodilation, and this may also partly account for their ability to prevent clinical events due to cardiovascular disease.
Similar articles
- [Estrogens and risks for onset of atherosclerosis].
Tedeschi-Reiner E, Reiner Z. Tedeschi-Reiner E, et al. Lijec Vjesn. 2001 May-Jun;123(5-6):135-41. Lijec Vjesn. 2001. PMID: 11554114 Review. Croatian. - Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg.
Nasr A, Breckwoldt M. Nasr A, et al. Gynecol Endocrinol. 1998 Feb;12(1):43-59. doi: 10.3109/09513599809024970. Gynecol Endocrinol. 1998. PMID: 9526710 Review. - Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
Burkman RT. Burkman RT. Fertil Steril. 1988 May;49(5 Suppl 2):39S-50S. Fertil Steril. 1988. PMID: 3282934 Review. - Noncontraceptive estrogen use and cardiovascular disease.
Bush TL, Barrett-Connor E. Bush TL, et al. Epidemiol Rev. 1985;7:89-104. Epidemiol Rev. 1985. PMID: 2996919 Review. - The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease.
Knopp RH. Knopp RH. Obstet Gynecol. 1988 Nov;72(5 Suppl):23S-30S. Obstet Gynecol. 1988. PMID: 3050656 Review.
Cited by
- Carotid Artery Calcification Detected on Panoramic Radiography Is Significantly Related to Cerebrovascular Accident, Coronary Artery Disease, and Poor Oral Health: A Retrospective Cross-Sectional Study.
Brar A, DeColibus K, Rasner DS, Haynes AR, Pancratz F, Oladiran O, Gbadamosi SO, Owosho AA. Brar A, et al. Dent J (Basel). 2024 Apr 10;12(4):99. doi: 10.3390/dj12040099. Dent J (Basel). 2024. PMID: 38668011 Free PMC article. - Atherosclerosis from Newborn to Adult-Epidemiology, Pathological Aspects, and Risk Factors.
Luca AC, David SG, David AG, Țarcă V, Pădureț IA, Mîndru DE, Roșu ST, Roșu EV, Adumitrăchioaiei H, Bernic J, Cojocaru E, Țarcă E. Luca AC, et al. Life (Basel). 2023 Oct 14;13(10):2056. doi: 10.3390/life13102056. Life (Basel). 2023. PMID: 37895437 Free PMC article. Review. - Glucose Transporter-2 Regulation of Male versus Female Hypothalamic Astrocyte MAPK Expression and Activation: Impact of Glucose.
Pasula M, Roy SC, Bheemanapally K, Sylvester PW, Briski KP. Pasula M, et al. Neuroglia. 2023 Sep;4(3):158-171. doi: 10.3390/neuroglia4030011. Epub 2023 Jun 21. Neuroglia. 2023. PMID: 37485036 Free PMC article. - Positive Association of Serum Galectin-3 with the Development of Aortic Stiffness of Patients on Peritoneal Dialysis.
Huang PY, Huang CS, Lin YL, Chen YH, Hung SC, Tsai JP, Hsu BG. Huang PY, et al. J Clin Med. 2023 May 17;12(10):3519. doi: 10.3390/jcm12103519. J Clin Med. 2023. PMID: 37240626 Free PMC article. - Changes to Urinary Proteome in High-Fat-Diet _ApoE_-/- Mice.
Hua Y, Meng W, Wei J, Liu Y, Gao Y. Hua Y, et al. Biomolecules. 2022 Oct 26;12(11):1569. doi: 10.3390/biom12111569. Biomolecules. 2022. PMID: 36358920 Free PMC article.